报价延迟最少15分钟:2026/06/21 14:06 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.46 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.74/-0.29
|
|
企业价值
4.61M
|
| 资产负债 |
|
每股账面净值
4.04
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions. |
